Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 140,000 shares at $7.46 ($1.1M) on 2020-04-01, disclosed to the SEC on 2020-04-03.
Open-market purchase of $1.1M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.46 | 70,000 | $522K | 49.1% |
| 2 | $7.73 | 70,000 | $541K | 50.9% |
| Total | $7.59 avg | 140,000 | $1.1M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |